The study aims to evaluate the feasibility of HIV self-testing (HIVST) delivery by a private pharmacy network among men who have sex with men (MSM) and transgender women (TGW) recruited through a classic and digital Respondent Driven Sampling method to improve HIV testing in Phnom Penh, Cambodia.
An interventional pilot study using a mixed qualitative and quantitative approach will be carried out in order to evaluate the feasibility, acceptability and appropriateness of the strategy and to identify barriers and facilitators.
To be aged from 18 years old (legal age in Cambodia)
For MSM, to have at least one oral or anal intercourse with another man in the past 12 months
For TGW, to be biologically a male at birth and self-identified as a woman or third gender and have at least one oral, anal or vaginal intercourse with another man in the past 12 months
Known HIV positive status
The survey population consists of MSM and TGW aged from 18 years old who are living in Phnom Penh at the study period regardless of their nationalities or migration history (moving from other provinces)
Other
Prospective
OraQuick
Diagnostic testThe intervention is based on respondent-driven sampling approach. Each selected seed from hotspots and on social networks is provided with two types of coupons for HIVST kit at partner pharmacy: electronic coupons (e-coupons) consisting of a pictured unique anonymous QR code and identifier and the address of pharmacies; paper coupons consisting of similar information to e-coupon. The seeds will then distribute coupons to their networks physically, via social media, and smart phone applications. Each recruited participant will bring the coupon to be scanned at the pharmacies to receive a free access HIVST kit. There, trained community worker will do the study visit including information/consent, e-CRF filling and providing link to send the test results. These recruited individuals will be considered as wave 1 and will each receive 10 additional coupons to recruit new members in the networks. The next round of individuals recruited and enrolled will be considered as wave 2, and so on.
Acceptability proportion of HIV self-test by MSM/TGW provided by private pharmacy
Number of HIV self-tests delivered / total number of coupons distributed
Acceptability and appropriateness provision of HIV self-test to MSM/TGW via private pharmacy
Group discussion using topic guides focusing on the comfortability, usefulness, suitability, confidentiality, credibility, advantages and barriers of provision of HIV self-test to MSM/TGW via private pharmacy among participants and private pharmacies
Click on the lead sponsor to view all of their trials.
ANRS, Emerging Infectious Diseases
Lead sponsor
Saglik Bilimleri Universitesi
Collaborator
Sciences économiques et sociales de la santé et traitement de l'information médicale Marseille France
Collaborator
National Center For HIV/AIDS, DERMATOLOGY AND STD Phnom Penh, Cambodia
Collaborator
Institut de Recherche pour le Developpement
Collaborator
This trial is not recruiting at the moment. You can still explore other options: